Your browser doesn't support javascript.
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.
Akter, Afroza; Ahmed, Tasnuva; Tauheed, Imam; Akhtar, Marjahan; Rahman, Sadia Isfat Ara; Khaton, Fatema; Ahmmed, Faisal; Ferdous, Jannatul; Afrad, Mokibul Hassan; Kawser, Zannat; Hossain, Mohabbat; Khondaker, Rabeya; Hasnat, Mohammad Abul; Sumon, Mostafa Aziz; Rashed, Asif; Ghosh, Shuvro; Calderwood, Stephen B; Charles, Richelle C; Ryan, Edward T; Khatri, Purvesh; Maecker, Holden Terry; Obermoser, Gerlinde; Pulendran, Bali; Clemens, John D; Banu, Sayera; Shirin, Tahmina; LaRocque, Regina C; Harris, Jason B; Bhuiyan, Taufiqur Rahman; Chowdhury, Fahima; Qadri, Firdausi.
  • Akter A; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Ahmed T; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Tauheed I; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Akhtar M; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Rahman SIA; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Khaton F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Ahmmed F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Ferdous J; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Afrad MH; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Kawser Z; Institute for Developing Science & Health Initiatives (ideSHi), Dhaka, Bangladesh.
  • Hossain M; Institute for Developing Science & Health Initiatives (ideSHi), Dhaka, Bangladesh.
  • Khondaker R; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Hasnat MA; Kurmitola General Hospital, Dhaka, Bangladesh.
  • Sumon MA; Kurmitola General Hospital, Dhaka, Bangladesh.
  • Rashed A; Mugda Medical College & Hospital, Dhaka, Bangladesh.
  • Ghosh S; Mugda Medical College & Hospital, Dhaka, Bangladesh.
  • Calderwood SB; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Charles RC; Departments of Medicine and Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Ryan ET; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Khatri P; Departments of Medicine and Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Maecker HT; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Obermoser G; Departments of Medicine and Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Pulendran B; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Clemens JD; Stanford University, Stanford, California, United States of America.
  • Banu S; Stanford University, Stanford, California, United States of America.
  • Shirin T; Stanford University, Stanford, California, United States of America.
  • LaRocque RC; Stanford University, Stanford, California, United States of America.
  • Harris JB; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
  • Bhuiyan TR; UCLA Fielding School of Public Health, Los Angeles, California, United States of America (JD Clemens MD).
  • Chowdhury F; Korea University School of Medicine, Seoul, South Korea (JD Clemens MD).
  • Qadri F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh).
PLoS Negl Trop Dis ; 16(1): e0010102, 2022 01.
Article in English | MEDLINE | ID: covidwho-1603353
ABSTRACT

BACKGROUND:

COVID-19 caused by SARS-CoV-2 ranges from asymptomatic to severe disease and can cause fatal and devastating outcome in many cases. In this study, we have compared the clinical, biochemical and immunological parameters across the different disease spectrum of COVID-19 in Bangladeshi patients. METHODOLOGY/PRINCIPAL

FINDINGS:

This longitudinal study was conducted in two COVID-19 hospitals and also around the community in Dhaka city in Bangladesh between November 2020 to March 2021. A total of 100 patients with COVID-19 infection were enrolled and classified into asymptomatic, mild, moderate and severe cases (n = 25/group). In addition, thirty age and sex matched healthy participants were enrolled and 21 were analyzed as controls based on exclusion criteria. After enrollment (study day1), follow-up visits were conducted on day 7, 14 and 28 for the cases. Older age, male gender and co-morbid conditions were the risk factors for severe COVID-19 disease. Those with moderate and severe cases of infection had low lymphocyte counts, high neutrophil counts along with a higher neutrophil-lymphocyte ratio (NLR) at enrollment; this decreased to normal range within 42 days after the onset of symptom. At enrollment, D-dimer, CRP and ferritin levels were elevated among moderate and severe cases. The mild, moderate, and severe cases were seropositive for IgG antibody by day 14 after enrollment. Moderate and severe cases showed significantly higher IgM and IgG levels of antibodies to SARS-CoV-2 compared to mild and asymptomatic cases. CONCLUSION/

SIGNIFICANCE:

We report on the clinical, biochemical, and hematological parameters associated with the different severity of COVID-19 infection. We also show different profile of antibody response against SARS-CoV-2 in relation to disease severity, especially in those with moderate and severe disease manifestations compared to the mild and asymptomatic infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Severity of Illness Index / COVID-19 / Antibodies, Viral Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS Negl Trop Dis Journal subject: Tropical Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Severity of Illness Index / COVID-19 / Antibodies, Viral Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS Negl Trop Dis Journal subject: Tropical Medicine Year: 2022 Document Type: Article